1-3 of 3
Lisha Ai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Bispecific CAR-T Cell Therapy Targeting Bcma and CD38 for Relapsed/Refractory Multiple Myeloma: Updated Results from a Phase 1 Dose-Climbing Trial

Chenggong Li, Heng Mei, Yu Hu, MD PhD, Tao Guo, MD PhD, Lin Liu, MD PhD, Huiwen Jiang, Lu Tang, Yaohui Wu, MD PhD, Lisha Ai, MD PhD, Jun Deng, MD PhD, Dan Jin
Journal: Blood
Blood (2019) 134 (Supplement_1): 930.
https://doi.org/10.1182/blood-2019-130340
Published: 2019
Journal Articles

Once Weekly Bortezomib Plus Dexamethasone in Newly Diagnosed Multiple Myeloma: A Preliminary Study in Chinese Patients

Yadan Wang, Yu Hu, MD, Lisha Ai, Bhuveshwarnath Gowrea, Guohui Cui, Jun Fang, MD, Chunyan Sun, Lu Zhang
Journal: Blood
Blood (2011) 118 (21): 5128.
https://doi.org/10.1182/blood.V118.21.5128.5128
Published: 2011
Journal Articles

Cardamonin, a Novel Blocker of STAT3 and Nuclear Factor-κB Activation, Suppresses Proliferation, Arrests Cell Cycle, and Potentiates Apoptosis In Human Multiple Myeloma Cells

You Qin, Chunyan Sun, Tao Guo, Yadan Wang, Lu Zhang, Lei Chen, Xiaomei She, Lisha Ai, Han Yan, Nicholas Miller Gregg, Jun Fang, Yu Hu
Journal: Blood
Blood (2010) 116 (21): 1820.
https://doi.org/10.1182/blood.V116.21.1820.1820
Published: 2010